[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100617501":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":12,"locations":17,"responsibleParty":32,"collaborators":7,"id":34,"slug":7,"hasResults":35,"nctId":36,"briefTitle":37,"officialTitle":38,"acronym":39,"eligibilityCriteria":40,"healthyVolunteers":35,"sex":41,"minAge":42,"maxAge":7,"enrollmentInfo":43,"targetDuration":46,"studyType":47,"phases":7,"briefSummary":48,"conditions":49,"keywords":53,"overallStatus":19,"whyStopped":7,"lastUpdateSubmitDate":65,"lastUpdatePostDateStruct":66,"startDateStruct":69,"completionDateStruct":71,"leadSponsor":73,"locationsCount":74},{"fullName":5,"class":6},"ImmunoRegister gUG","OTHER",null,[9],{"name":10,"affiliation":5,"role":11},"Stefanie Howaldt, MD","PRINCIPAL_INVESTIGATOR",[13],{"name":10,"role":14,"phone":15,"phoneExt":7,"email":16},"CONTACT","+4940423265150","Howaldt@immunoregister.de",[18],{"facility":5,"status":19,"city":20,"state":7,"zip":21,"country":22,"cosmosGeoPoint":23,"geoPoint":28,"contacts":29},"RECRUITING","Hamburg","20251","Germany",{"type":24,"coordinates":25},"Point",[26,27],9.99302,53.55073,{"lat":27,"lon":26},[30],{"name":10,"role":14,"phone":31,"phoneExt":7,"email":16},"+4930423265150",{"type":33,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100617501",false,"NCT07319442","CEDUR - German IBD Registry","Long-term Observation of IBD Patients, a Nationwide German IBD Registry \"CEDUR\"","CEDUR","Inclusion Criteria:\n\n* Crohn Disease Ulcerative Colitis Indterminate Colitis\n\nExclusion Criteria:\n\n* Other gastrointestinal disorders than above","ALL","18 Years",{"count":44,"type":45},10000,"ESTIMATED","10 Years","OBSERVATIONAL","The CEDUR registry systematically collects real-world data on inflammatory bowel disease (IBD) patients in Germany. The registry aims to assess quality of care, disease activity, treatment effectiveness, safety, and pharmacoeconomic aspects under routine clinical conditions.",[50,51,52],"Ulcerative Colitis (UC)","Indeterminate Colitis","Crohn Disease (CD)",[54,55,56,57,58,22,59,60,61,62,63,64],"IBD","Registry","Crohn's disease","Ulcerative Colitis","Real-world-data","Quality of care","pharmaeconomics","safety","long-term follow-up","patient journey","treatment algorithm","2025-12-21",{"date":67,"type":68},"2026-01-06","ACTUAL",{"date":70,"type":68},"2018-05-03",{"date":72,"type":45},"2036-05",{"name":5,"class":6},1]